About Index Trending news
Lists
Pricing
Merrimack

Merrimack

Merrimack

We are committed to the fight against cancer. We seek to understand the complexity of the disease and engineer life-saving solutions through our science.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Private equity
$77,000,000
Undisclosed funding
Employees

Team size

200+
Locations
HQ
Xconomy

Merrimack Hits Reset Button, Sells Cancer Drugs to Ipsen For $575M

Health Strategy Earnings
Xconomy

Still Stuck Below IPO Price, Merrimack Restructures, CEO Resigns

Health Earnings
The Motley Fool

Here's Why Merrimack Pharmaceuticals' Stock Has Been Getting Crushed in 2016

The Motley Fool

Why Merrimack Pharmaceuticals' Stock Is Sliding Today